Seki, T
"Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding." Biochemical and Biophysical Research Communications
The secondary research was used to obtain critical information on the industrys value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives
But at Meritain Health, we believe its not meant to be this way
Our findings clarify why GLP-1 but not GIP-based therapies are effective in T2D and also provide a mechanism accounting for the increase in basal insulin secretion that is a characteristic feature of the disease (i.e., chronic hyperglycemia leads to reduced K ATP channel activity that leads to stimulation of cell electrical activity, which leads to activation of Gq, thereby resulting in elevated basal insulin secretion)
Sermorelin works slowly and may take weeks to show effects